CDKN1C and cancer: Based on the roles played by the protein in the nuclear compartment, currently, it is considered a tumor suppressor; however, differently from p27Kip1 [143], somatic mutations have been rarely reported in tumors [145,146], underlining the importance of p57Kip2 expression control as the main cause of its altered levels in cancer.